Response to Brandt, Bednarz-Knoll, Kleinheinz et al
Open Access
- 1 June 2020
- journal article
- letter
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 112 (9), 970-971
- https://doi.org/10.1093/jnci/djaa075
Abstract
Anil K Chaturvedi, PhD, Natalia Udaltsova, PhD, Eric A Engels, MD, MPH, Jed A Katzel, MD, Elizabeth L Yanik, PhD, Hormuzd A Katki, PhD, Mark W Lingen, DDS, PhD,This publication has 5 references indexed in Scilit:
- RE: Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort StudyJNCI Journal of the National Cancer Institute, 2020
- Erlotinib and the Risk of Oral CancerJAMA Oncology, 2016
- Teaching Moment: Why Promising Biomarkers Do Not Always Translate Into Clinically Useful TestsJournal of Clinical Oncology, 2014
- From Differences in Means between Cases and Controls to Risk Stratification: A Business Plan for Biomarker DevelopmentCancer Discovery, 2013
- Treatment and follow‐up of oral dysplasia — A systematic review and meta‐analysisHead & Neck, 2009